Emergent BioSolutions Inc (EBS)
10.02
+0.17
(+1.73%)
USD |
NYSE |
Nov 26, 16:00
10.02
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Revenue (TTM): 1.094B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.094B |
| June 30, 2024 | 1.074B |
| March 31, 2024 | 1.158B |
| December 31, 2023 | 1.023B |
| September 30, 2023 | 1.076B |
| June 30, 2023 | 1.035B |
| March 31, 2023 | 938.80M |
| December 31, 2022 | 1.079B |
| September 30, 2022 | 1.389B |
| June 30, 2022 | 1.479B |
| March 31, 2022 | 1.616B |
| December 31, 2021 | 1.639B |
| September 30, 2021 | 1.568B |
| June 30, 2021 | 1.615B |
| March 31, 2021 | 1.614B |
| December 31, 2020 | 1.462B |
| September 30, 2020 | 1.236B |
| June 30, 2020 | 1.153B |
| March 31, 2020 | 984.50M |
| December 31, 2019 | 983.50M |
| September 30, 2019 | 891.60M |
| June 30, 2019 | 770.80M |
| March 31, 2019 | 772.30M |
| December 31, 2018 | 705.30M |
| September 30, 2018 | 638.82M |
| Date | Value |
|---|---|
| June 30, 2018 | 616.63M |
| March 31, 2018 | 492.70M |
| December 31, 2017 | 490.40M |
| September 30, 2017 | 416.74M |
| June 30, 2017 | 394.94M |
| March 31, 2017 | 373.66M |
| December 31, 2016 | 345.40M |
| September 30, 2016 | 376.17M |
| June 30, 2016 | 393.61M |
| March 31, 2016 | 426.01M |
| December 31, 2015 | 385.20M |
| September 30, 2015 | 343.22M |
| June 30, 2015 | 308.26M |
| March 31, 2015 | 304.83M |
| December 31, 2014 | 312.79M |
| September 30, 2014 | 305.51M |
| June 30, 2014 | 287.92M |
| March 31, 2014 | 266.06M |
| December 31, 2013 | 257.92M |
| September 30, 2013 | 246.60M |
| June 30, 2013 | 224.32M |
| March 31, 2013 | 211.88M |
| December 31, 2012 | 215.88M |
| September 30, 2012 | 178.50M |
| June 30, 2012 | 183.25M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
938.80M
Minimum
Mar 2023
1.639B
Maximum
Dec 2021
1.261B
Average
1.156B
Median
Revenue (TTM) Benchmarks
| Abbott Laboratories | 41.22B |
| Tonix Pharmaceuticals Holding Corp | 11.29M |
| Geovax Labs Inc | -- |
| SIGA Technologies Inc | 173.73M |
| Chimerix Inc | -- |